Clinical Trial
Intelligence Agents
CTIA completes the BioMedAI pipeline — bringing AI intelligence to clinical trial design, site selection, patient stratification, and real-world evidence synthesis. Pharmacovigilance is live now. More agents in development.
- Pharmacovigilance
- Predictive patient recruitment
- AI-assisted protocol design
- Portfolio optimization
- Digital twin trial simulation
Clinical Trials Are Broken at Scale
The industry's clinical execution challenges compound the already high cost of drug discovery. CTIA is being built to address these directly.
Clinical trials represent the biggest bottleneck in drug development — not because the science is wrong, but because trial design, site selection, and patient recruitment rely on outdated processes.
- Sites are selected on historical relationships, not real-time patient data
- Protocol design doesn't leverage prior trial intelligence
- Patient eligibility screening is manual and error-prone
- Real-world evidence is siloed and underutilized in trial planning
- Mid-trial adaptations happen too slowly without AI monitoring
What CTIA Delivers
Shape What We Build Next
Pharmacovigilance is live. Tell us your clinical trial challenge — your input directly shapes which CTIA agent we build next.
Book a 30-min Discovery CallNo commitment. We're listening.
The Full BioMedAI Pipeline — DBRA Live, CTIA Launching
From target discovery to clinical intelligence — explore the complete DBRA → ADDA → CTIA pipeline.